期刊文献+

乳酸左氧氟沙星胃漂浮缓释片的制备及体外评价 被引量:2

PREPARATION AND IN VITRO RELEASE OF LEVOFLOXACIN LACTATE INTRA-GASTRIC FLOATING SUSTAINED RELEASE TABLETS
下载PDF
导出
摘要 目的制备乳酸左氧氟沙星胃漂浮缓释片,考察其漂浮性和体外释放行为。方法以湿法制粒压片法制备乳酸左氧氟沙星胃漂浮缓释片,分别考察处方中各辅料对制剂漂浮性和体外释放行为的影响。结果处方中羟丙基甲基纤维素(hypromellose cellulose,HPMC)黏度规格、用量及十八醇、碳酸氢钠用量对制剂的漂浮性或体外释放行为均有影响,处方中HPMC K_(100M)量为100mg/片、十八醇用量为40mg/片、碳酸氢钠用量为40mg/片时其漂浮性能和释放行为较好。结论本制剂具有良好的胃漂浮和缓释效果,且工艺稳定性好。 Objective To investigate the preparation of levofloxacin floating sustained release tablets and study their in vitro release.Methods The tablets were prepared by wet granulation tabletting,and effect of different excipients on the tablets' floating and release property was evaluated.Results The viscosity and amount of Hypromellose Cellulose,amount of octadecanol and sodium bicarbonate could influence the tablets' floating or release property.The tablets showed a good sustainedrelease and floating property with HPMC K100M 100mg/tablet,sodium bicarbonate 40mg/tablet,octadecanol 40mg/tablet.Conclusion The tablets had good floating and release charactiristics,and showed good process stability.
出处 《河北医科大学学报》 CAS 2013年第10期1169-1172,共4页 Journal of Hebei Medical University
基金 河北省科学技术研究与发展计划项目(11217183)
关键词 左氧氟沙星 迟效制剂 药物评价 ofloxacin delayed-action preparations drug evaluation
  • 相关文献

参考文献8

二级参考文献42

  • 1Saad RJ,Schoenfeld P,Kim HM.左氧氟沙星三联疗法治疗顽固性Hp感染优于铋剂四联疗法[J].中国处方药,2006,5(5):42-42. 被引量:40
  • 2曲莉,王智民,仝燕.胃滞留漂浮型缓控释制剂的研究概况[J].中国实验方剂学杂志,2006,12(7):66-70. 被引量:13
  • 3李松龙,茹仁萍,庄辉耀,上官盈盈,赵文霞.甘草酸二铵胃内滞留漂浮型缓释片的制备及体外释放[J].中国医院药学杂志,2007,27(1):94-96. 被引量:11
  • 4Xu G Groves MJ.Effect of FITC-dextran mo1ecu1ar weight on its re1ease from f1oating cety1 a1coho1 and HPMC tab1ets [J].J Pharm Pharmaco1,2001,53(1):49-56.
  • 5Malfertheiner P,Megraud F,O'Morain C,et al Current concepts in the management of Helicobacter pylori infection the MaastichtⅢ Consensus Report Gut,2007,56 6):772-781.
  • 6Uemeura N,Okamoto S,Mukai T,et al.Effect of helicobacter pylori eradication on the healing and recurrence of pepcic ulcer:combination therapy with low-dose omeprazole and clarithroimycin.Eur J Gastroenterol Hepatol,1995,7(Suppll):67-89.
  • 7Ling TK,Cheng AF,Sung JJ,et al.Impact of Helicobacter pylori resistance to metronidazole:a five year study.Helicobacter,1996,1(1):57-61.
  • 8Korsmeyer RW,Gurny R, Doelker E, et al. Mechanism of solute release from porous hydrophilic polymers[J].Int J Pharm, 1983,28 : 25-35.
  • 9Ritger PL, Peppas NA. A simple equation for description of solute release II. Fickian and anomalous expression from swellable devices[J]. J Control Rel, 1987,5 : 37-42.
  • 10Klausner EA, Eya S, Lavy E,et al. Novel levodopa gas-tro re tentive dosage form: in vivo evaluation in dogs[J]. J Control Release, 2003,88(1 ) : 117.

共引文献70

同被引文献26

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部